Nano-X Imaging (NASDAQ:NNOX) Price Target Lowered to $9.00 at Cantor Fitzgerald

Nano-X Imaging (NASDAQ:NNOX) had its price objective decreased by Cantor Fitzgerald from $12.00 to $9.00 in a report issued on Tuesday morning,Benzinga reports. Cantor Fitzgerald currently has an overweight rating on the stock.

Separately, D. Boral Capital restated a “buy” rating and set a $15.00 price target on shares of Nano-X Imaging in a research note on Monday.

Nano-X Imaging Stock Down 3.2 %

NASDAQ:NNOX opened at $4.83 on Tuesday. The stock has a market capitalization of $279.07 million, a price-to-earnings ratio of -5.68 and a beta of 1.99. Nano-X Imaging has a 52 week low of $4.61 and a 52 week high of $11.39. The firm has a 50 day moving average of $6.48 and a 200 day moving average of $6.63.

Nano-X Imaging (NASDAQ:NNOX) last issued its quarterly earnings data on Monday, March 31st. The company reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.08). Nano-X Imaging had a negative net margin of 465.38% and a negative return on equity of 27.63%. The business had revenue of $3.00 million for the quarter, compared to analysts’ expectations of $3.80 million. As a group, analysts expect that Nano-X Imaging will post -0.92 EPS for the current year.

Institutional Investors Weigh In On Nano-X Imaging

A number of large investors have recently made changes to their positions in the stock. US Bancorp DE raised its stake in Nano-X Imaging by 388.7% in the 4th quarter. US Bancorp DE now owns 3,470 shares of the company’s stock worth $25,000 after acquiring an additional 2,760 shares during the last quarter. Quadrant Capital Group LLC raised its stake in shares of Nano-X Imaging by 464.9% in the fourth quarter. Quadrant Capital Group LLC now owns 7,016 shares of the company’s stock worth $51,000 after purchasing an additional 5,774 shares during the last quarter. Quantum Private Wealth LLC acquired a new stake in shares of Nano-X Imaging during the fourth quarter worth about $72,000. Signaturefd LLC lifted its holdings in shares of Nano-X Imaging by 164.6% during the fourth quarter. Signaturefd LLC now owns 10,391 shares of the company’s stock worth $75,000 after purchasing an additional 6,464 shares during the period. Finally, PharVision Advisers LLC purchased a new stake in Nano-X Imaging in the fourth quarter valued at approximately $80,000. 21.49% of the stock is owned by hedge funds and other institutional investors.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.